Archived News
In August 2021 Finfeed changed from a website that covered ASX listed news to a website
that covered a select range of ASX
listed small cap Biotech stocks that we are personally
invested in: find out more.
The old Finfeed website, and all of the old articles are kept here for record keeping purposes.
VISIT NEW SITEStrong April sales trigger 30% increase in Harris’ share price
2 minute read
Harris Technology Group Limited (ASX:HT8) provided a promising trading update on Tuesday, resulting in its shares increasing more than 30%.
In mid-April, Harris announced that unaudited revenue for the March 2020 quarter had significantly increased and was expected to be sustained at similar levels for the foreseeable future.
It was at that time that the group established the Pro-Hygiene range of products including facemasks, hand sanitiser gels and alcohol wipes.
Harris has been authorised by China’s Jointown Pharmaceutical Group (one of the leading medical supply and distribution companies in China) to distribute its Jointown and Aumacom face masks.
The company sold an initial 30,000 face masks in March, and a new shipment of 200,000 TGA approved face masks were imported for sale in late April.
Revenue from the Pro-Hygiene range for the June 2020 quarter was estimated to be $400,000.
Sales revenue for April 2020 for both the IT/CE (Consumer Electronics Division) and the Pro-Hygiene division was just over $2.7 million.
This compares with sales revenue (unaudited) for the full March 2020 quarter of $3.4 million and sales for the April - June 2019 quarter (audited) of $2.23 million.
Having already eclipsed June 2019 quarter sales, as well as sales generated in the March 2020 quarter in just one month, Harris is positioned to finish the fiscal year strongly.
E-commerce business also tracking while
Sales of Pro-Hygiene products alone for April 2020 were $1.05 million (unaudited) with strong gross margins of 20%.
Consequently, in just one month Pro-Hygiene sales have exceeded the June quarter guidance by 150%.
Harris has expanded its product range by securing the non-exclusive Australian distribution rights for the “Tender Kiss” brand of alcohol tissues from Guangzhou Baihua Sanitary Products Co.
The tissues are being imported from China and sales of the brand will commence this month.
Harris is confident that supplies of products in China should continue, and the distribution rights are ongoing with no specific termination date.
A national network of sales agents to sell Pro-Hygiene products has been established, and one agent has been appointed for each state of Australia.
Harris had another record-breaking month, generating substantial sales growth through its IT/CE e-commerce business in April 2020. Unaudited sales revenue was $1.68 million.
Management will be providing a profit update in the coming weeks, which based on recent developments could be a share price catalyst.
Latest articles on Harris Technology Group Limited
More Commentary
Creso Pharma’s vital competitive advantages key to the future
06-07-2021
BDA finishes fiscal 2021 on a high
01-07-2021
Why CPH investors should care about The HighBrid Lab
24-06-2021
Creso and Red Light Holland to merge into The HighBrid Lab
17-06-2021S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
Publishers Notice
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain.